BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Govaerts K, Lurvink RJ, De Hingh IHJT, Van der Speeten K, Villeneuve L, Kusamura S, Kepenekian V, Deraco M, Glehen O, Moran BJ; PSOGI. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 2021;47:11-35. [PMID: 32199769 DOI: 10.1016/j.ejso.2020.02.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Lopes A, de Mello ES, Mendoza Lopez RV, Leonardi PC, Ribeiro U Jr. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. J Surg Res 2022;274:68-76. [PMID: 35123285 DOI: 10.1016/j.jss.2022.01.001] [Reference Citation Analysis]
2 Martín-Román L, Lozano P, Vásquez W, Palencia N, Gómez Y, Fernández-Aceñero MJ, González-Bayón L. Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review. BJS Open 2021;5:zrab059. [PMID: 34355239 DOI: 10.1093/bjsopen/zrab059] [Reference Citation Analysis]
3 Foster JM, Alexander HR, Zhang C. Regional therapy trials in peritoneal metastases: The path to standardization of care: Introduction. J Surg Oncol 2021. [PMID: 34762306 DOI: 10.1002/jso.26750] [Reference Citation Analysis]
4 Derbal S, Klapczynski C, Charissoux A, Durand Fontanier S, Taibi A. Management of mucocele of the appendix with peritoneal dissemination in pregnant women: a case report and literature review. Acta Chir Belg 2021;:1-7. [PMID: 34266364 DOI: 10.1080/00015458.2021.1956800] [Reference Citation Analysis]
5 Flatmark K, Mohamed F. ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method. Ann Surg Oncol 2020;27:771-2. [PMID: 32495284 DOI: 10.1245/s10434-020-08691-4] [Reference Citation Analysis]
6 Martín-Román L, Lozano P, Gómez Y, Fernández-Aceñero MJ, Vasquez W, Palencia N, González-Bayón L. Which classification system defines best prognosis of mucinous neoplasms of the appendix with peritoneal dissemination: TNM vs PSOGI? J Clin Pathol 2021:jclinpath-2021-207883. [PMID: 34725195 DOI: 10.1136/jclinpath-2021-207883] [Reference Citation Analysis]
7 Gronau F, Feldbruegge L, Oberwittler F, Gonzalez-Moreno S, Villeneuve L, Eveno C, Glehen O, Kusamura S, Rau B. HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques. J Clin Med 2022;11:1456. [PMID: 35268546 DOI: 10.3390/jcm11051456] [Reference Citation Analysis]
8 Calabrò ML, Lazzari N, Rigotto G, Tonello M, Sommariva A. Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments. Int J Mol Sci 2020;21:E9120. [PMID: 33266161 DOI: 10.3390/ijms21239120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Brennan DJ, Moran BJ. Time to Evolve Terminology from "Debulking" to Cytoreductive Surgery (CRS) in Ovarian Cancer. Ann Surg Oncol 2021. [PMID: 34304313 DOI: 10.1245/s10434-021-10490-4] [Reference Citation Analysis]
10 Soucisse ML, Lansom J, Alshahrani MS, Morris DL. Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review. ANZ Journal of Surgery 2020;90:1888-94. [DOI: 10.1111/ans.16185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Trilling B, Brind'Amour A, Hamad R, Tremblay JF, Dubé P, Mitchell A, Sidéris L. Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index. World J Surg Oncol 2021;19:60. [PMID: 33622339 DOI: 10.1186/s12957-021-02171-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Delhorme JB, Villeneuve L, Bouché O, Averous G, Dohan A, Gornet JM, You B, Bibeau F, Dartigues P, Eveno C, Fontaine J, Kepenekian V, Pocard M, Rousset P, Quenet F, Mariani P, Glehen O, Goéré D. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis 2022;54:30-9. [PMID: 34815194 DOI: 10.1016/j.dld.2021.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 van de Vlasakker VCJ, Lurvink RJ, Cashin PH, Ceelen W, Deraco M, Goéré D, González-Moreno S, Lehmann K, Li Y, Moran B, Morris DL, Piso P, Quadros CA, Rau B, Somashekhar SP, Sommariva A, van der Speeten K, Spiliotis J, Sugarbaker PH, Teo MCC, Verwaal VJ, Yonemura Y, Glehen O, de Hingh IHJT. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol 2021:S0748-7983(21)00499-6. [PMID: 34020808 DOI: 10.1016/j.ejso.2021.05.023] [Reference Citation Analysis]
14 Istl AC, Gage MM, Esquivel J, Ahuja N, Greer JB, Johnston FM. Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPEC. Ann Surg Oncol 2021;28:3831-7. [PMID: 33393023 DOI: 10.1245/s10434-020-09312-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cortés-Guiral D, Hübner M, Alyami M, Bhatt A, Ceelen W, Glehen O, Lordick F, Ramsay R, Sgarbura O, Van Der Speeten K, Turaga KK, Chand M. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers 2021;7:91. [PMID: 34916522 DOI: 10.1038/s41572-021-00326-6] [Reference Citation Analysis]
16 Sofia C, Marino MA, Milone E, Ieni A, Blandino A, Ascenti G, Macrì A. Pseudomyxoma peritonei involving the canal of Nuck: The added value of magnetic resonance imaging for detection and presurgical planning. Radiology Case Reports 2022;17:1887-9. [DOI: 10.1016/j.radcr.2022.03.011] [Reference Citation Analysis]
17 Ye S, Zheng S. Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei: A Literature Review. Am J Clin Oncol 2022;45:223-31. [PMID: 35446281 DOI: 10.1097/COC.0000000000000911] [Reference Citation Analysis]
18 Santullo F, Pacelli F, Abatini C, Attalla El Halabieh M, Fortunato G, Lodoli C, Giovinazzo F, Rotolo S, Di Giorgio A. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience. Front Surg 2021;8:715119. [PMID: 34513915 DOI: 10.3389/fsurg.2021.715119] [Reference Citation Analysis]
19 Kostov S, Kornovski Y, Slavchev S, Ivanova Y, Dzhenkov D, Yordanov A, Slavcheva S. Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer - a case report with literature review. Prz Menopauzalny 2021;20:148-53. [PMID: 34703416 DOI: 10.5114/pm.2021.109120] [Reference Citation Analysis]
20 Iinuma S, Hayashi K, Ishida-Yamamoto A. Pseudomyxoma peritonei with peristomal skin metastasis. Int J Dermatol 2021. [PMID: 34714931 DOI: 10.1111/ijd.15952] [Reference Citation Analysis]
21 Liang L, Fang J, Han X, Zhai X, Song Y, Lu Y, Zhang Q, Ma R. Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei. Front Oncol 2021;11:594763. [PMID: 34733775 DOI: 10.3389/fonc.2021.594763] [Reference Citation Analysis]
22 Sommariva A, Tonello M, Rigotto G, Lazzari N, Pilati P, Calabrò ML. Novel Perspectives in Pseudomyxoma Peritonei Treatment. Cancers (Basel) 2021;13:5965. [PMID: 34885075 DOI: 10.3390/cancers13235965] [Reference Citation Analysis]
23 Yamanaka K, Iizuka N, Kitai T. A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei. Surg Case Rep 2021;7:251. [PMID: 34862939 DOI: 10.1186/s40792-021-01332-2] [Reference Citation Analysis]
24 Matias-García B, Mendoza-Moreno F, Blasco-Martínez A, Busteros-Moraza JI, Diez-Alonso M, Garcia-Moreno Nisa F. A retrospective analysis and literature review of neoplastic appendiceal mucinous lesions. BMC Surg 2021;21:79. [PMID: 33573654 DOI: 10.1186/s12893-021-01091-9] [Reference Citation Analysis]
25 Rauwerdink P, Brosens LAA, van Diepen KK, Ghedri ON, Kranenburg O, Boerma D, Witkamp AJ, van Grevenstein HMU. Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel. World J Surg Oncol 2022;20:147. [PMID: 35538541 DOI: 10.1186/s12957-022-02613-2] [Reference Citation Analysis]
26 Mielko J, Rawicz-Pruszyński K, Sędłak K, Gęca K, Kwietniewska M, Polkowski WP. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes. Cancers (Basel) 2020;12:E2387. [PMID: 32842535 DOI: 10.3390/cancers12092387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Lin YL, Li Y. The Biological Synthesis and the Function of Mucin 2 in Pseudomyxoma Peritonei. Cancer Manag Res 2021;13:7909-17. [PMID: 34703312 DOI: 10.2147/CMAR.S324982] [Reference Citation Analysis]
28 Flood MP, Kong JC, Pham T, Waters PS, Soucisse M, Ramsay R, Wong H, Mitchell C, Michael M, Mccormick JJ, Warrier S, Akhurst T, Heriot A. Diagnostic performance of positron emission tomography in the staging of Pseudomyxoma peritonei. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.02.003] [Reference Citation Analysis]
29 Glehen O, Kepenekian V, Bouché O, Gladieff L, Honore C; RENAPE-BIG-RENAPE. Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups. J Visc Surg 2020;157:S25-31. [PMID: 32387058 DOI: 10.1016/j.jviscsurg.2020.04.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
30 Santullo F, Abatini C, Attalla El Halabieh M, Ferracci F, Lodoli C, Barberis L, Giovinazzo F, Di Giorgio A, Pacelli F. The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis. Front Surg 2022;9:877970. [DOI: 10.3389/fsurg.2022.877970] [Reference Citation Analysis]
31 Glehen O, Kepenekian V, Bouché O, Gladieff L, Honore C; RENAPE-BIG-RENAPE. [Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups]. J Chir Visc 2020;157:S25-32. [PMID: 32328206 DOI: 10.1016/j.jchirv.2020.04.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Kiyokawa T. Peritoneal Pathology Review. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.005] [Reference Citation Analysis]